首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Properties of permease dimer a fusion protein containing two lactose permease molecules from Escherichia coli.
【2h】

Properties of permease dimer a fusion protein containing two lactose permease molecules from Escherichia coli.

机译:渗透酶二聚体的特性一种融合蛋白含有两个来自大肠杆菌的乳糖渗透酶分子。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An engineered fusion protein containing two tandem lactose permease molecules (permease dimer) exhibits high transport activity and is used to test the phenomenon of negative dominance. Introduction of the mutation Glu-325-->Cys into either the first or the second half of the dimer results in a 50% decrease in activity, whereas introduction of the mutation into both halves of the dimer abolishes transport. Lactose transport by permease dimer is completely inactivated by N-ethylmaleimide; however, 40-45% activity is retained after N-ethylmaleimide treatment when either the first or the second half of the dimer is replaced with a mutant devoid of cysteine residues. The observations demonstrate that both halves of the fusion protein are equally active and suggest that each half may function independently. To test the possibility that oligomerization between dimers might account for the findings, a permease dimer was constructed that contains two different deletion mutants that complement functionally when expressed as untethered molecules. Because this construct does not catalyze lactose transport to any extent whatsoever, it is unlikely that the two halves of the dimer interact or that there is an oligomeric interaction between dimers. The approach is consistent with the contention that the functional unit of lactose permease is a monomer.
机译:包含两个串联的乳糖通透酶分子(通透酶二聚体)的工程融合蛋白具有较高的转运活性,可用于测试负优势现象。将突变体Glu-325-> Cys引入二聚体的前半部分或后半部分会使活性降低50%,而将突变引入二聚体的两半则消除了转运。透过酶二聚体的乳糖运输被N-乙基马来酰亚胺完全灭活;然而,当N-乙基马来酰亚胺处理后,当用没有半胱氨酸残基的突变体代替二聚体的前半部分或后半部分时,保留了40-45%的活性。观察结果表明,融合蛋白的两半均具有相同的活性,并表明每一半均可独立发挥功能。为了测试二聚体之间的寡聚可能解释这一发现的可能性,构建了一个通透酶二聚体,其包含两个不同的缺失突变体,这些突变体在表达为非束缚分子时功能上互补。因为该构建体在任何程度上均不催化乳糖运输,所以二聚体的两半相互作用或二聚体之间不存在寡聚相互作用的可能性很小。该方法与乳糖通透酶的功能单元是单体的观点一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号